Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Mar 03, 2024 11:48am
59 Views
Post# 35912018

RE:RE:RE:RE:Net Present Value

RE:RE:RE:RE:Net Present Value
Tencents wrote: The Covid 19 potentiel was clearly indicated by dr ask as being in the circumstances of the pandemic 
WHO has downgraded Covid 19 as non pandemic 
Its unlikely the findings of dr ask will attract any interest now within  the Covid 19 space 


In the summer of 2020 as the pandemic had us sheltering in place;

"Hoping for favorable pre-clinical results, preparations of a Phase 1/2 clinical trial protocol will be commenced immediately and planned to be submitted to Health Authorities during Q4 2020"

There could have been real developments to have help in getting this study going and genuine interest could have helped the stock price move up and if needed attract capital. Of course with Gille, it's just another example of ineptitude. He was too comfortable already shetering in place remotely in Sherbroke to really care about moving this forward expeditiously. BTW, 4 years later, where does Y-BG ( for fibrosis) stand now, oh yeah, tolerability studies with no timeline or will to move forward.

Let's get a capable CEO who believes in timelines and when the world was shut down, could have cared enough to advance PGX Y-BG.
<< Previous
Bullboard Posts
Next >>